1-4 of 4
Mathias Rummel, MD
Close
Sort by
Journal Articles

Outcomes for Elderly Patients (pts) with Follicular Lymphoma (FL) Using Individual Patient Data (IPD) from 5922 Pts in 18 Randomized Controlled Trials (RCTs): a Follicular Lymphoma Analysis of Surrogate Hypothesis (FLASH) Group Study

Christopher Flowers, MDMS, Fang-Shu Ou, PhD, Qian Shi, PhD, Eva Hoster, PhD, Bruce A. Peterson, MD, Howard S. Hochster, MD, Pauline Brice, MD, Marco Ladetto, MD, Wolfgang Hiddemann, MD, Robert E Marcus, Eva Kimby, MD PhD, Michael Herold, Sabine De Bedout, MD MPH, Tina Nielsen, Franck Morschhauser, Mathias Rummel, MD PhD, Anton Hagenbeek, MD PhD, Umberto Vitolo, Gilles A. Salles, Daniel Sargent, PhD
Journal: Blood
Blood (2016) 128 (22): 1102.
https://doi.org/10.1182/blood.V128.22.1102.1102
Published: 2016
Journal Articles

Effects on Survival and Neurocognitive Functions of Whole-Brain Radiotherapy (WBRT) and Autologous Stem Cell Transplantation (ASCT) as Consolidation Options after High-Dose Methotrexate-Based Chemoimmunotherapy in Patients with Newly Diagnosed Primary CNS Lymphoma (PCNSL): Results of the Second Randomization of the IELSG32 Trial

Andrés J.M. Ferreri, MD, Kate Cwynarski, MBBS, FRPATH, PhD, Elisa Jacobsen Pulczynski, MD, Christopher P. Fox, MBChB, PhD, Elisabeth Schorb, MD, Paul La Rosée, MD, Mascha Binder, MD, Alberto Fabbri, MD, Valter Torri, MD, Eleonora Minacapelli, MD, Monica Falautano, MD, Fiorella Ilariucci, MD, Achille Ambrosetti, MD, Alexander Röth, MD, Claire Jane Hemmaway, MD, Peter M Johnson, MA, MD, Kim Linton, MBChB, MRCP, PhD, Tobias Pukrop, MD, Jette Sonderskov Gorlov, MD, Monica Balzarotti, MD, Georg Hess, MD, Ulrich Keller, MD, Stephan Stilgenbauer, MD, Jens P. Panse, MD, Alessandra Tucci, MD, Lorella Orsucci, MD, Francesco Pisani, MD, Alessandro Levis, MD, Stefan W. Krause, MD, Hans-Joachim Schmoll, MD PhD, Bernd Hertenstein, MD, Mathias Rummel, MD PhD, Jeffery Smith, MD, Michael Pfreundschuh, MD, PhD, Giuseppina Cabras, MD, Francesco Angrilli, MD, Maurilio Ponzoni, MD, Martina Deckert, MD, Letterio S. Politi, MD, Jurgen Finke, MD, Michele Reni, MD, Franco Cavalli, Emanuele Zucca, Gerald Illerhaus, MD
Journal: Blood
Blood (2016) 128 (22): 511.
https://doi.org/10.1182/blood.V128.22.511.511
Published: 2016
Journal Articles

Prefmab: Final Analysis of Patient Preference for Subcutaneous Versus Intravenous Rituximab in Previously Untreated CD20+ Diffuse Large B-Cell Lymphoma and Follicular Lymphoma

Mathias Rummel, MD PhD, Tae Min Kim, MD PhD, Caterina Plenteda, MD, Enrico Capochiani, MD, Maria Mendoza, Rodney Smith, MD PhD, Stuart Osborne, MSc, Andrew Grigg, MBBS, MD FRACP, FRACPA
Journal: Blood
Blood (2015) 126 (23): 3972.
https://doi.org/10.1182/blood.V126.23.3972.3972
Published: 2015
Journal Articles

All-Trans Retinoic Acid and Gemtuzumab Ozogamicin as Adjunct to High-Dose Cytarabine-Based Salvage Therapy in Primary Refractory Acute Myeloid Leukemia: Results of AMLSG 05-04 Trial.

Richard F. Schlenk, MD, Konstanze Döhner, MD, Jürgen Krauter, MD, Daniela Späth, Francesco de Valle, MD, Björn Heydrich, MD, Heinz A. Horst, MD, Ingo Schmidt-Wolf, MD, Mathias Rummel, MD, Katharina Götze, MD, Elisabeth Koller, MD, Andreas Petzer, MD, Hans G. Mergenthaler, MD, Hans Salwender, MD, Walter Fiedler, MD, Heinz Kirchen, MD, Detlef Haase, MD, Stefan Krämers, MD, Matthias Theobald, MD, Axel C. Matzdorff, MD, Arnold Ganser, MD, Hartmut Döhner, MD
Journal: Blood
Blood (2007) 110 (11): 1837.
https://doi.org/10.1182/blood.V110.11.1837.1837
Published: 2007